A groundbreaking study on the coelacanth has uncovered shocking truths about its anatomy, revealing that many previously identified evolutionary muscle novelties were incorrect. This research reshapes our understanding of vertebrate evolution.
In a surprising turn of events, the FDA has allowed Sarepta Therapeutics to resume shipments of its gene therapy, Elevidys, for younger Duchenne muscular dystrophy patients who can walk, despite concerns over previous fatalities.
Bubba Wallace celebrates a monumental win at the Brickyard 400, marking his third Cup victory and ending a 100-race dry spell. With support from his crew and newfound motivation, he aims to become an iconic figure in NASCAR history.
As gene therapy for Duchenne muscular dystrophy faces scrutiny after tragic deaths, families like the Revells navigate the uncertain waters of hope and risk, questioning the future of their loved ones.
Get ready for a hilarious ride as 'Happy Gilmore 2' hits Netflix on July 25! With Adam Sandler back in action, the film is packed with surprise cameos from stars like Travis Kelce and Eminem. Don't miss out on the laughter!
A groundbreaking study reveals that building muscle might be a natural alternative to Viagra, linking muscle quality to erectile dysfunction. Discover how exercise and diet can enhance sexual health!
Sarepta Therapeutics' gene therapy for Duchenne muscular dystrophy is on hold due to safety issues. An FDA official warns the path to market approval is fraught with challenges, especially after patient deaths linked to liver injuries.
The Venice Film Festival 2025 is set to dazzle with a lineup featuring world premieres from acclaimed directors like Jim Jarmusch and Noah Baumbach. From star-studded casts to thrilling documentaries, this festival promises an unforgettable cinematic experience!
Are you one of the many Americans using GLP-1 drugs like Ozempic or Wegovy? Discover essential lifestyle tips to prevent nutrient deficiencies and muscle loss while maximizing your weight loss results!
In a stunning move, the FDA has put clinical trials for Sarepta's gene therapy on hold due to alarming safety concerns after multiple patient deaths linked to acute liver failure. The company faces scrutiny as it navigates the fallout.
